Status:
NOT_YET_RECRUITING
Effect of Topical Bromelain Versus Topical Corticosteroids in the Management of Recurrent Aphthous Stomatitis
Lead Sponsor:
Cairo University
Conditions:
Recurrent Aphthous Stomatitis
Eligibility:
All Genders
18-60 years
Phase:
PHASE2
Brief Summary
Bromelain, a natural product, exhibits anti-inflammatory, immunomodulatory, and wound-healing properties. However, its efficacy in treating oral mucosal ulcers remains unexplored. This study aims to e...
Eligibility Criteria
Inclusion
- Adults aged 18-60 years.
- Diagnosed with RAS.
- Onset of ulcer within the last 48 hours.
- Willingness to participate and provide informed consent.
Exclusion
- History of hematological deficiencies, GIT disorders, Behcet's disease and major systemic diseases.
- Pregnant or breastfeeding patients.
- Previous treatment for the current ulcer episode.
Key Trial Info
Start Date :
June 15 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 15 2026
Estimated Enrollment :
63 Patients enrolled
Trial Details
Trial ID
NCT06993337
Start Date
June 15 2025
End Date
June 15 2026
Last Update
May 28 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.